Biomimetic Asymmetric Reduction of Quinazolinones with Chiral and Regenerable<scp>NAD</scp>(P)H Models
作者:Zi‐Biao Zhao、Xiang Li、Bo Wu、Yong‐Gui Zhou
DOI:10.1002/cjoc.202000045
日期:2020.7
A facile approach to chiral dihydroquinazolinone derivatives has been described via biomimetic asymmetric reduction of quinazolinones with chiral and regenerable NAD(P)Hmodels. The utility of this method was demonstrated by a concise synthesis of the bromodomain protein divalent inhibitor.
Polyquinazolines and methods for their preparation
申请人:Hitachi Chemical Co., Ltd.
公开号:US05686560A1
公开(公告)日:1997-11-11
New polyquinazoline polymers are provided by reacting novel monomers, The polymers incorporate repeat units that have at least one quinazoline nucleus and at least one ether linkage at the quniazoline 2 or 4 position. The quinazoline polymers are prepared by treating a monomer which comprises a quinazolone nucleus having one activated halide group with a base in a dipolar solvent to thereby form the polyquinazoline polymer.